Skip to main content
Erschienen in: Archives of Dermatological Research 5/2024

01.07.2024 | Short Report

Use of complementary and alternative medicine in vitiligo: a cross-sectional survey

verfasst von: Sneha Poondru, Lynna J. Yang, Roopal V. Kundu

Erschienen in: Archives of Dermatological Research | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Vitiligo is characterized by skin depigmentation, which can lead to profound psychological effects and decreased quality of life, especially for those with skin of color. Individuals with vitiligo may utilize complementary and alternative medicine (CAM) due to limited treatment options with varying efficacy.
An anonymous, multiple-choice, cross-sectional questionnaire was distributed to participants with vitiligo in the United States through online forums. Data on disease characteristics, use of prescription medications, use of topical therapies, supplements, and diets, and perceptions of CAM were collected.
In total, 625 respondents completed the survey. Overall, 32.5% of participants (203/625) have tried CAM. Commonly reported CAM include supplements of vitamin D (57.7%, 116/203), vitamin B12 (46.3%, 93/203), vitamin C (27.4%, 55/203), topical Nigella sativa oil (26.4%, 53/203), oral omega-3 fatty acids (24.9%, 50/203), folic acid (22.9%, 46/203), and vitamin E (22.9%, 46/203). Frequently cited reasons for CAM use include desire to try “new” (40.4%, 82/203) or “more natural” (26.6%, 54/203) therapies, “frustration with conventional medicine” (24.6%, 50/203), and fear of “adverse side effects of conventional medicine” (23.6%, 48/203). Non-White participants were more likely than their White counterparts to report CAM use and have more positive perceptions of CAM therapies. Less than half (43.3%, 88/203) of CAM users reported that they disclosed their use of CAM with their physician.
Dermatologists should be mindful of CAM and ask patients about their use. Further investigation of the role of CAM as adjuvant therapy for vitiligo is warranted to better advise patients.
Literatur
1.
Zurück zum Zitat Shakhbazova A et al (2021) A Systematic Review of Nutrition, supplement, and herbal-based adjunctive therapies for Vitiligo. J Altern Complement Med 27(4):294–311CrossRefPubMed Shakhbazova A et al (2021) A Systematic Review of Nutrition, supplement, and herbal-based adjunctive therapies for Vitiligo. J Altern Complement Med 27(4):294–311CrossRefPubMed
2.
Zurück zum Zitat Elzahrani M et al (2020) Perceptions, knowledge, and attitudes toward complementary and alternative medicine among Saudi patients with vitiligo. Acta Dermatovenerol Alp Pannonica Adriat 29(4):165–168PubMed Elzahrani M et al (2020) Perceptions, knowledge, and attitudes toward complementary and alternative medicine among Saudi patients with vitiligo. Acta Dermatovenerol Alp Pannonica Adriat 29(4):165–168PubMed
3.
Zurück zum Zitat Bhalla M, Thami GP (2010) Factors predicting the preference of complementary and alternative systems of medicine in treatment of vitiligo. Indian J Dermatol Venereol Leprol 76(6):705–707CrossRefPubMed Bhalla M, Thami GP (2010) Factors predicting the preference of complementary and alternative systems of medicine in treatment of vitiligo. Indian J Dermatol Venereol Leprol 76(6):705–707CrossRefPubMed
4.
5.
Zurück zum Zitat Simpson EL, Basco M, Hanifin J (2003) A cross-sectional survey of complementary and alternative medicine use in patients with atopic dermatitis. Am J Contact Dermat 14(3):144–147PubMed Simpson EL, Basco M, Hanifin J (2003) A cross-sectional survey of complementary and alternative medicine use in patients with atopic dermatitis. Am J Contact Dermat 14(3):144–147PubMed
6.
Zurück zum Zitat Damevska K et al (2014) Complementary and alternative medicine use among patients with psoriasis. Dermatol Ther 27(5):281–283CrossRefPubMed Damevska K et al (2014) Complementary and alternative medicine use among patients with psoriasis. Dermatol Ther 27(5):281–283CrossRefPubMed
7.
Zurück zum Zitat Saleh HM, Abdel Fattah NS, Hamza HT (2013) Evaluation of serum 25-hydroxyvitamin D levels in vitiligo patients with and without autoimmune diseases. Photodermatol Photoimmunol Photomed 29(1):34–40CrossRefPubMed Saleh HM, Abdel Fattah NS, Hamza HT (2013) Evaluation of serum 25-hydroxyvitamin D levels in vitiligo patients with and without autoimmune diseases. Photodermatol Photoimmunol Photomed 29(1):34–40CrossRefPubMed
8.
Zurück zum Zitat Karagüzel G et al (2016) Vitamin D status and the effects of oral vitamin D treatment in children with vitiligo: a prospective study. Clin Nutr ESPEN 15:28–31CrossRefPubMed Karagüzel G et al (2016) Vitamin D status and the effects of oral vitamin D treatment in children with vitiligo: a prospective study. Clin Nutr ESPEN 15:28–31CrossRefPubMed
9.
Zurück zum Zitat Watabe A et al (2018) Efficacy of oral cholecalciferol on rhododendrol-induced vitiligo: a blinded randomized clinical trial. J Dermatol 45(4):456–462CrossRefPubMed Watabe A et al (2018) Efficacy of oral cholecalciferol on rhododendrol-induced vitiligo: a blinded randomized clinical trial. J Dermatol 45(4):456–462CrossRefPubMed
10.
Zurück zum Zitat Juhlin L, Olsson MJ (1997) Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. Acta Derm Venereol 77(6):460–462CrossRefPubMed Juhlin L, Olsson MJ (1997) Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. Acta Derm Venereol 77(6):460–462CrossRefPubMed
11.
Zurück zum Zitat Tjioe M et al (2002) Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 82(5):369–372CrossRefPubMed Tjioe M et al (2002) Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol 82(5):369–372CrossRefPubMed
12.
Zurück zum Zitat Elgoweini M, Din NNE (2009) Response of vitiligo to narrowband ultraviolet B and oral antioxidants. J Clin Pharmacol 49(7):852–855CrossRefPubMed Elgoweini M, Din NNE (2009) Response of vitiligo to narrowband ultraviolet B and oral antioxidants. J Clin Pharmacol 49(7):852–855CrossRefPubMed
13.
Zurück zum Zitat Ghorbanibirgani A, Khalili A, Rokhafrooz D (2014) Comparing Nigella sativa Oil and Fish Oil in Treatment of Vitiligo. Iran Red Crescent Med J 16(6):e4515CrossRefPubMedPubMedCentral Ghorbanibirgani A, Khalili A, Rokhafrooz D (2014) Comparing Nigella sativa Oil and Fish Oil in Treatment of Vitiligo. Iran Red Crescent Med J 16(6):e4515CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Calapai G et al (2014) Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - part 1: Achillea millefolium-Curcuma longa. Contact Dermat 71(1):1–12CrossRef Calapai G et al (2014) Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - part 1: Achillea millefolium-Curcuma longa. Contact Dermat 71(1):1–12CrossRef
Metadaten
Titel
Use of complementary and alternative medicine in vitiligo: a cross-sectional survey
verfasst von
Sneha Poondru
Lynna J. Yang
Roopal V. Kundu
Publikationsdatum
01.07.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 5/2024
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-024-02872-x

Weitere Artikel der Ausgabe 5/2024

Archives of Dermatological Research 5/2024 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.